NKTT120 Reduces iNKT Cells without Dose Limiting Toxicity in Stable Adult Sickle Cell Patients in a Phase 1 Trial - Majerus, Elaine M.; Ataga, Kenneth I.; Vichinsky, Elliott; Eaton, Cheryl A.; Mazanet, Rosemary; Nathan, David G.; Field, Joshua J. (Blood, 2014)